Lentitek is a cell and gene therapy company.
Lentitek has raised $902K in total funding. The most recent round was Seed. The last funding was announced in March 2025.
Lentitek's investors include Scottish Enterprise, Innovate UK, University of Edinburgh, Equity Gap, Apollo Informal Investment.
Lentitek is headquartered in Edinburgh, United Kingdom.
Lentitek is a cell and gene therapy company.
Lentitek is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lentitek — Funding & Investors." VCBacked, March 5, 2025, https://www.vcbacked.co/company/lentitek. Accessed August 15, 2026.
VCBacked. (2025). Lentitek — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/lentitek
{{cite web |title=Lentitek — Funding & Investors |url=https://www.vcbacked.co/company/lentitek |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated